396 related articles for article (PubMed ID: 16789799)
41. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
Millson DS; Tepper SJ; Rapoport AM
Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
[TBL] [Abstract][Full Text] [Related]
42. Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States.
Sheftell F; Ryan R; Pitman V;
Headache; 2003 Mar; 43(3):202-13. PubMed ID: 12603638
[TBL] [Abstract][Full Text] [Related]
43. [Clinical use of triptans in the management of migraine].
Lantéri-Minet M
CNS Drugs; 2006; 20 Spec no.1():12-23. PubMed ID: 16841523
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration.
Milton KA; Scott NR; Allen MJ; Abel S; Jenkins VC; James GC; Rance DJ; Eve MD
J Clin Pharmacol; 2002 May; 42(5):528-39. PubMed ID: 12017347
[TBL] [Abstract][Full Text] [Related]
45. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
Almas M; Tepper SJ; Landy S; Schweizer E; Ramos E
Cephalalgia; 2014 Feb; 34(2):126-35. PubMed ID: 23946318
[TBL] [Abstract][Full Text] [Related]
46. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks.
Stark R; Dahlöf C; Haughie S; Hettiarachchi J;
Cephalalgia; 2002 Feb; 22(1):23-32. PubMed ID: 11993610
[TBL] [Abstract][Full Text] [Related]
47. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
[TBL] [Abstract][Full Text] [Related]
48. Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine.
Steiner TJ; Diener HC; MacGregor EA; Schoenen J; Muirheads N; Sikes CR
Cephalalgia; 2003 Dec; 23(10):942-52. PubMed ID: 14984226
[TBL] [Abstract][Full Text] [Related]
49. Individual triptan selection in migraine attack therapy.
Belvís R; Pagonabarraga J; Kulisevsky J
Recent Pat CNS Drug Discov; 2009 Jan; 4(1):70-81. PubMed ID: 19149716
[TBL] [Abstract][Full Text] [Related]
50. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care.
Nett RB; Tiseo PJ; Almas M; Sikes CR
Int J Clin Pract; 2007 Oct; 61(10):1677-85. PubMed ID: 17877653
[TBL] [Abstract][Full Text] [Related]
51. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
Johnson DE; Rollema H; Schmidt AW; McHarg AD
Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
[TBL] [Abstract][Full Text] [Related]
52. Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
Mullins CD; Weis KA; Perfetto EM; Subedi PR; Healey PJ
J Manag Care Pharm; 2005 Jun; 11(5):394-402. PubMed ID: 15934798
[TBL] [Abstract][Full Text] [Related]
53. Rational migraine management: optimising treatment with the triptans.
Millson DS
Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
[TBL] [Abstract][Full Text] [Related]
54. Eletriptan: pharmacological differences and clinical results.
Giffin N
Curr Med Res Opin; 2001; 17 Suppl 1():s59-62. PubMed ID: 12463280
[TBL] [Abstract][Full Text] [Related]
55. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
56. Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.
Mathew NT; Schoenen J; Winner P; Muirhead N; Sikes CR
Headache; 2003 Mar; 43(3):214-22. PubMed ID: 12603639
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
58. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
Färkkilä M; Olesen J; Dahlöf C; Stovner LJ; ter Bruggen JP; Rasmussen S; Muirhead N; Sikes C
Cephalalgia; 2003 Jul; 23(6):463-71. PubMed ID: 12807526
[TBL] [Abstract][Full Text] [Related]
59. [Economic evaluation of acute migraine attack treatment with triptans in Spain].
Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P
Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947
[TBL] [Abstract][Full Text] [Related]
60. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Deleu D; Hanssens Y
J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
